RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CABIBBO G
Collezione AOU Novara

Items : 7

Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2025 Feb 3;31(3):543-550. doi: 10.1158/1078-0432.CCR-24-2582.

2025
AOU Novara

Cabibbo G; Celsa C; Battaglia S; Enea M; Di Maria G; Grova A; Ciccia R; Manfredi GF; Iavarone M; Vogel A; Singal AG; Reig M; Pinato DJ; Cammà C;

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours. in Journal of hepatology / J Hepatol. 2024 Mar;80(3):431-442. doi: 10.1016/j.jhep.2023.10.040. Epub 2023 Nov 15.

2024
AOU Novara

Celsa C; Cabibbo G; Fulgenzi CAM; Scheiner B; D'Alessio A; Manfredi GF; Nishida N; Ang C; Marron TU; Saeed A; Wietharn B; Pinter M; Cheon J; Huang YH; Lee PC; Phen S; Gampa A; Pillai A; Vivaldi C; Salani F; Masi G; Roehlen N; Thimme R; Vogel A; Schönlein M; von Felden J; Schulze K; Wege H; Galle PR; et alii...

Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept. in The Lancet. Oncology / Lancet Oncol. 2023 Jul;24(7):e312-e322. doi: 10.1016/S1470-2045(23)00186-9.

2023
AOU Novara

Vitale A; Cabibbo G; Iavarone M; Viganò L; Pinato DJ; Ponziani FR; Lai Q; Casadei-Gardini A; Celsa C; Galati G; Gambato M; Crocetti L; Renzulli M; Giannini EG; Farinati F; Trevisani F; Cillo U;

Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis. in Cancers / Cancers (Basel). 2023 Jan 6;15(2):381. doi: 10.3390/cancers15020381.

2023
AOU Novara

Giacomelli L; Papa S; Giordano G; Dadduzio V; Gadaleta-Caldarola G; Paolillo R; Giannini EG; Pieri G; Mega A; Granito A; Marzi L; Masi G; Cesario S; Rancatore G; Cabibbo G; Cocuzza C; Russello M; Gallo P; Silletta M; Daniele B; Federico P; Pirisi M; Burlone ME; di Costanzo GG; Tortora R; Ramai D; Sacco R; Renzulli M; Maida M; et alii...

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. in Journal of hepatocellular carcinoma / J Hepatocell Carcinoma. 2023 Nov 3;10:1955-1971. doi: 10.2147/JHC.S291553. eCollection 2023.

2023
AOU Novara

Donadon M; Rigamonti C; Burlone M; Vincenzi F; Minisini R; Pirisi M; Mauri FA; Gennari A; Pinter M; Korolewicz J; Fulgenzi CAM; Scheiner B; Acuti N; Jones C; John C; Celsa C; Manfredi GF; Cabibbo G; D'Alessio A; Pinato DJ;

Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2022 Jun;54(6):722-726. doi: 10.1016/j.dld.2022.03.014. Epub 2022 Mar 28.

2022
AOU Novara

Lleo A; Cazzagon N; Rigamonti C; Cabibbo G; Lai Q; Muratori L; Carbone M;

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis. in ESMO open / ESMO Open. 2022 Dec;7(6):100591. doi: 10.1016/j.esmoop.2022.100591. Epub 2022 Oct 6.

2022
AOU Novara

Rimini M; Rimassa L; Ueshima K; Burgio V; Shigeo S; Tada T; Suda G; Yoo C; Cheon J; Pinato DJ; Lonardi S; Scartozzi M; Iavarone M; Di Costanzo GG; Marra F; Soldà C; Tamburini E; Piscaglia F; Masi G; Cabibbo G; Foschi FG; Silletta M; Pressiani T; Nishida N; Iwamoto H; Sakamoto N; Ryoo BY; Chon HJ; Claudia F; et alii...